- Report
- August 2024
- 132 Pages
Global
From €1982EUR$2,243USD£1,746GBP
€2642EUR$2,990USD£2,328GBP
- Report
- August 2022
- 325 Pages
Global
From €2320EUR$2,625USD£2,044GBP
€3093EUR$3,500USD£2,725GBP
- Report
- August 2020
- 292 Pages
Global
From €2320EUR$2,625USD£2,044GBP
€3093EUR$3,500USD£2,725GBP
- Report
- April 2020
- 233 Pages
Global
From €2320EUR$2,625USD£2,044GBP
€3093EUR$3,500USD£2,725GBP
- Report
- November 2023
- 120 Pages
Global
From €5258EUR$5,950USD£4,632GBP
- Report
- August 2024
- 170 Pages
Global
From €3977EUR$4,500USD£3,503GBP
- Report
- October 2023
- 113 Pages
Global
From €3977EUR$4,500USD£3,503GBP
- Report
- August 2022
- 118 Pages
Global
From €3977EUR$4,500USD£3,503GBP
- Report
- August 2022
- 116 Pages
Global
From €3977EUR$4,500USD£3,503GBP
- Report
- October 2021
- 100 Pages
Global
From €3977EUR$4,500USD£3,503GBP
- Report
- June 2022
- 43 Pages
Global
From €2165EUR$2,450USD£1,907GBP
- Report
- February 2023
- 155 Pages
Global
From €2200EUR$2,490USD£1,939GBP
- Report
- December 2024
- 200 Pages
Global
From €3314EUR$3,750USD£2,919GBP
- Report
- January 2024
- 200 Pages
Global
From €3667EUR$4,150USD£3,231GBP
- Report
- January 2024
- 200 Pages
Global
From €3667EUR$4,150USD£3,231GBP
- Report
- April 2025
- 70 Pages
Saudi Arabia
From €3093EUR$3,500USD£2,725GBP
- Report
- December 2024
- 85 Pages
India
From €3093EUR$3,500USD£2,725GBP
- Report
- July 2024
- 150 Pages
Global
From €2651EUR$3,000USD£2,336GBP
€3314EUR$3,750USD£2,919GBP
- Report
- July 2024
- 100 Pages
Global
From €2651EUR$3,000USD£2,336GBP
€3314EUR$3,750USD£2,919GBP
- Report
- July 2024
- 150 Pages
Global
From €2651EUR$3,000USD£2,336GBP
€3314EUR$3,750USD£2,919GBP

Injectables and infusions are medical treatments that involve the administration of drugs or other substances directly into the body. Injectables are typically administered through a needle or syringe, while infusions are typically administered through a catheter or intravenous line. Injectables and infusions are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases.
The injectable market is a rapidly growing segment of the pharmaceutical industry. It is estimated that the global injectable market is worth over $100 billion and is expected to grow at a compound annual growth rate of over 8%. The market is driven by the increasing prevalence of chronic diseases, the growing demand for biologics, and the increasing use of self-injectable drugs.
Some of the major players in the injectable market include Pfizer, Merck, Sanofi, Novartis, and Johnson & Johnson. Other companies in the market include Amgen, Bristol-Myers Squibb, Eli Lilly, and AstraZeneca. Show Less Read more